Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday.
StockWatch: M&A Talk Fuels Cytokinetics Stock Roller Coaster genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
PRINCETON, N.J., Jan. 16, 2024 PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease.
Cytokinetics Deal Rumors Take Traders on White-Knuckle Ride bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Cytokinetics Deal Rumors Take Traders on White-Knuckle Ride yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.